Resources
November 16, 2020
Join the Biosimilars Council along with 17 other IGBA associations in building awareness of the benefits of biosimilars.
November 10, 2020
Today, the U.S. Supreme Court will hear arguments on the constitutionality of the Affordable Care Act (ACA). Although the case relates to the individual insurance mandate contained in the law, it could affect more than just this question.
October 26, 2020
The Biologics Price Competition and Innovation Act of 2010 (BPCIA) provides a framework for biosimilars approval, adoption and access in the U.S.
October 22, 2020
It is essential that cancer patients can access medicine through the pandemic and beyond. Generics and biosimilars can offer much-needed treatments with substantial cost savings.
October 12, 2020
Patent abuse and anti-competitive activities limit the ability of biosimilars to reach the market in a timely manner and ultimately hurt patients.
October 5, 2020
The biosimilar development process has three major stages: characterization and perfecting the process, confirmation of biosimilarity and approval.
